250
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Development and anti-Candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel

, , , , , , & show all
Pages 829-839 | Received 19 Sep 2017, Accepted 25 Jan 2018, Published online: 05 Feb 2018

References

  • Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961–1971.
  • Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, Martinez-de-Oliveira J. New strategies for local treatment of vaginal infections. Adv Drug Deliv Rev. 2015;92:105–122.
  • Eckert LO, Hawes SE, Stevens CE. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol. 1998;92:757–765.
  • Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161–189.
  • Niemirowicz K, Durnas B, Piktel E, et al. Development of antifungal therapies using nanomaterials. Nanomedicine (Lond). 2017;12:1891–1905.
  • Mathur M, Devi VK. Potential of novel drug delivery systems in the management of topical candidiasis. J Drug Target. 2017;25:685–703.
  • Brotherton MC, Bourassa S, Legare D, et al. Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum. Int J Parasitol Drugs Drug Resist. 2014;4:126–132.
  • Luengo-Alonso C, Torrado JJ, Ballesteros MP, et al. A novel performing PEG-cholane nanoformulation for amphotericin B delivery. Int J Pharm. 2015;495:41–51.
  • Dinh T, Zia Q, Zubair S, et al. Novel biodegradable poly(gamma-glutamic acid)–amphotericin B complexes show promise as improved amphotericin B formulations. Nanomed-Nanotechnol Biol Med. 2017;13:1773–1783.
  • King CT, Rogers PD, Cleary JD, et al. Antifungal therapy during pregnancy. Clin Infect Dis. 1998;27:1151–1160.
  • Kayser O, Olbrich C, Yardley V, et al. Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm. 2003;254:73–75.
  • Tauber A, Mueller-Goymann CC. In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model. Int J Pharm. 2016;505:20–23.
  • Figueroa-Ochoa EB, Villar-Alvarez EM, Cambon A, et al. Lenghty reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) polymeric micelles and gels for sustained release of antifungal drugs. Int J Pharm. 2016; 510:17–29.
  • Park S-C, Kim Y-M, Lee J-K, et al. Targeting and synergistic action of an antifungal peptide in an antibiotic drug-delivery system. J Control Release. 2017;256:46–55.
  • Soliman GM. Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int J Pharm. 2017;523:15–32.
  • Zaioncz S, Khalil NM, Mainardes RM. Exploring the role of nanoparticles in amphotericin B delivery. Curr Pharm Des. 2017;23:509–521.
  • Liu M, Chen M, Yang Z. Design of amphotericin B oral formulation for antifungal therapy. Drug Deliv. 2017;24:1–9.
  • Acarturk F. Mucoadhesive vaginal drug delivery systems. Ddf. 2009;3:193–205.
  • Szymanska E, Winnicka K, Amelian A, et al. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine. Chem Pharm Bull. 2014;62:160–167.
  • Moon HJ, Ko DY, Park MH, et al. Temperature-responsive compounds as in situ gelling biomedical materials. Chem Soc Rev. 2012;41:4860–4883.
  • He CL, Kim SW, Lee DS. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release. 2008;127:189–207.
  • Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev. 2008;37:1473–1481.
  • Joo MK, Park MH, Choi BG, et al. Reverse thermogelling biodegradable polymer aqueous solutions. J Mater Chem. 2009;19:5891–5905.
  • Caramella CM, Rossi S, Ferrari F, et al. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv Drug Deliv Rev. 2015;92:39–52.
  • Li T, Ci T, Chen L, et al. Salt-induced reentrant hydrogel of poly(ethylene glycol)-poly(lactide-co-glycolide) block copolymers. Polym Chem. 2014;5:979–991.
  • Alexandridis P, Hatton TA. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block-copolymer surfactants in aqueous-solutions and at interfaces - thermodynamics, structure, dynamics, and modeling. Colloid Surf A-Physicochem Eng Asp. 1995;96:1–46.
  • Zhao L-Y, Zhang W-M. Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives. J Drug Target. 2017;25:471–484.
  • Kang J-W, Davaa E, Kim Y-T, et al. A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel. J Drug Target. 2010;18:637–644.
  • Kim Y-T, Shin B-K, Garripelli VK, et al. A thermosensitive vaginal gel formulation with HPγCD for the pH-dependent release and solubilization of amphotericin B. Eur J Pharm Sci. 2010;41:399–406.
  • das Neves J, Nunes R, Machado A, et al. Polymer-based nanocarriers for vaginal drug delivery. Adv Drug Deliv Rev. 2015;92:53–70.
  • Ruel-Gariepy E, Leroux JC. In situ-forming hydrogels-review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58:409–426.
  • Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 2009;365:175–179.
  • Overstreet DJ, Dutta D, Stabenfeldt SE, et al. Injectable hydrogels. J Polym Sci B Polym Phys. 2012;50: 881–903.
  • Zhang L, Pan J, Dong S, et al. The application of polysaccharide-based nanogels in peptides/proteins and anticancer drugs delivery. J Drug Target. 2017;25:673–684.
  • Ravani L, Esposito E, Bories C, et al. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies. Int J Pharm. 2013;454:695–702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.